Bopindolol
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | C07AA17 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 69010-88-4 |
PubChem (CID) | 44112 |
DrugBank | DB08807 |
ChemSpider | 40146 |
UNII | KT304VZO57 |
KEGG | D07537 |
ChEMBL | CHEMBL357995 |
Chemical and physical data | |
Formula | C23H28N2O3 |
Molar mass | 380.48 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Bopindolol (INN) is a beta blocker. It is an ester which acts as a prodrug for its active metabolite 4-(3-t-butylamino-2-hydroxypropoxy)-2-methylindole.[1]
References
- ↑ Nagatomo T, Hosohata Y, Ohnuki T, Nakamura T, Hattori K, Suzuki J, Ishiguro M (Spring 2001). "Bopindolol: pharmacological basis and clinical implications". Cardiovasc Drug Rev. 19 (1): 9–24. doi:10.1111/j.1527-3466.2001.tb00180.x. PMID 11314603.
This article is issued from Wikipedia - version of the 6/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.